Senate Committee Takes Up Co-pay Accumulators Reform Bill
Update: May 2-15, 2026
The Senate Finance, Insurance and Consumer Protection Committee recently took up testimony on SB 914, introduced by Stephanie Chang (D-Detroit). The bill would require prescription drug co-pay assistance to count toward a patient’s deductible and out-of-pocket maximum.
Supporters of the bill include patient advocacy groups that represent individuals with serious conditions such as cancer, blood disorders, epilepsy, and other diseases that require patients to rely on costly medications. Supporting organizations argue that the bill would reduce unexpected out-of-pocket costs for patients, while simultaneously improving affordability and transparency in drug pricing.
Opposition comes primarily from insurers and health plans, who argue the policy would influence patients to purchase more expensive brand name medications versus cheaper generic options. It has also been suggested that co-pay coupons increase the cost of brand name medications over time.
The bill is now waiting on a Committee vote.